Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Pierre Fabre Medicament
National Institutes of Health Clinical Center (CC)
Duke University
University of Rochester
Scripps Translational Science Institute
Roswell Park Cancer Institute
Shwachman-Diamond Syndrome Alliance Inc